Immunovant, Inc.

IMVT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Dec 9, 2019
4 Dec 5, 2019
4 Dec 4, 2019
4 Dec 3, 2019
DEFA14A Dec 2, 2019 FORM 8-K
8-K Dec 2, 2019 FORM 8-K
4 Nov 29, 2019
DEFR14A Nov 29, 2019 REVISED DEFINITIVE PROXY STATEMENT
DEFM14A Nov 27, 2019
DEFA14A Nov 25, 2019 CURRENT REPORT
8-K Nov 25, 2019 CURRENT REPORT
PRER14A Nov 25, 2019 PROXY STATEMENT
4 Nov 22, 2019
UPLOAD Nov 22, 2019
4 Nov 19, 2019
4 Nov 14, 2019
DEFA14A Nov 14, 2019 CURRENT REPORT
8-K Nov 14, 2019 CURRENT REPORT
10-Q Nov 13, 2019 QUARTERLY REPORT
4 Nov 12, 2019
DEFA14A Nov 12, 2019 CURRENT REPORT
8-K Nov 12, 2019 CURRENT REPORT
PRER14A Nov 6, 2019 PRELMINARY PROXY STATEMENT
CORRESP Nov 5, 2019
UPLOAD Oct 31, 2019
← Newer Page 24 of 26 · 646 filings Older →